The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram;
Arnone, D, Wise, T, Walker, C, Cowen, PJ, Howes, O & Selvaraj, S 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol 84, pp. 152-159. DOI: 10.1016/j.pnpbp.2018.01.021

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia;
Lew, MF, Brashear, A, Dashtipour, K, Isaacson, S, Hauser, RA, Maisonobe, P, Snyder, D & Ondo, W 2017, International Journal of Neuroscience, pp. 1-8. DOI: 10.1080/00207454.2017.1406935

Sports and Headaches;
Evans, RW 2018, Headache. DOI: 10.1111/head.13263

A Survey of Neurologists on Postconcussion Syndrome;
Evans, RW & Ghosh, K 2018, Headache. DOI: 10.1111/head.13272

Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia;
Lin, CC & Ondo, WG 2018, Journal of the Neurological Sciences. DOI: 10.1016/j.jns.2018.02.014

An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis;
Fournier, CN, Schoenfeld, D, Berry, JD, Cudkowicz, ME, Chan, J, Quinn, C, Brown, RH, Salameh, JS, Tansey, MG, Beers, DR, Appel, SH & Glass, JD 2018, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1-8. DOI: 10.1080/21678421.2017.1421666

Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study;
Selvaraj, S, Walker, C, Arnone, D, Cao, B, Faulkner, P, Cowen, PJ, Roiser, JP & Howes, O 2018, Neuropsychopharmacology, vol 43, no. 3, pp. 655-664. DOI: 10.1038/npp.2017.166

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study;
Skrobot, OA, Black, SE, Chen, C, DeCarli, C, Erkinjuntti, T, Ford, GA, Kalaria, RN, OBrien, J, Pantoni, L, Pasquier, F, Roman, GC, Wallin, A, Sachdev, P, Skoog, I, Ben-Shlomo, Y, Passmore, AP, Love, S & Kehoe, PG 2017, Alzheimers and Dementia. DOI: 10.1016/j.jalz.2017.09.007

Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report;
Allen, RP, Picchietti, DL, Auerbach, M, Cho, YW, Connor, JR, Earley, CJ, Garcia-Borreguero, D, Kotagal, S, Manconi, M, Ondo, W, Ulfberg, J, Winkelman, JW, On behalf of the & International Restless Legs Syndrome Study Group (IRLSSG) 2018, Sleep Medicine, vol 41, pp. 27-44. DOI: 10.1016/j.sleep.2017.11.1126

Treating Hallucinations and Delusions Associated With Parkinson’s Disease Psychosis;
Panchal, SC & Ondo, WG 2018, Current Psychiatry Reports, vol 20, no. 1, 3. DOI: 10.1007/s11920-018-0869-z